Effect of Dabigatran on the Ability to Generate Fibrin at a Wound site and its Reversal by Idarucizumab, the Antidote to Dabigatran, in Healthy Volunteers: An Exploratory Marker of Blood Loss Circulation - van Ryn, J; Schmoll, M; Pillu, H (2014)
(abstract).